Pharma Journalist -

PixarBio Corporation developers of NeuroRelease NR14, a 14-day post-surgical pain treatment, announces an agreement between Particle Sciences (PSI), a Lubrizol Corporation Company, to…
Read More...

Regeneron Pharmaceuticals and ISA Pharmaceuticals announced a clinical collaboration to advance ISA101, an immunotherapy targeting human papillomavirus type 16 (HPV16)-induced cancer,…
Read More...

Aldevron, a provider of contract plasmid DNA manufacturing, protein production and antibody discovery services, and Integrated DNA Technologies, Inc. (IDT), a supplier of custom nucleic…
Read More...

SSCI, part of AMRI’s Global Analytical Services, will expand its nuclear magnetic resonance (NMR) spectroscopy capabilities with the addition of the Bruker AVANCE NEO 600 MHz NMR…
Read More...

Renova Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the company's lead product candidate, RT-100 AC6 gene transfer…
Read More...

CMC ICOS Biologics and Harpoon Therapeutics announced that they have entered into an agreement for the development and manufacturing of HPN424, HPN536, and HPN217, representing three…
Read More...

Aprecia Pharmaceuticals and Cycle Pharmaceuticals announced they have signed a partnership agreement to develop and commercialize  orphan drugs using three-dimensionally printed…
Read More...

Medicure announced that, through its subsidiary, Medicure International Inc., it has acquired, from a large multinational pharmaceutical company, an exclusive license to sell and market…
Read More...

BioVectra Inc., an innovative global contract development and manufacturing organization (CDMO), announced a long-term supply agreement with Keryx Biopharmaceuticals, Inc., to…
Read More...

Pfizer Inc. announced that the United States Food and Drug Administration (FDA) has approved XELJANZ® 5 mg twice daily (BID) and XELJANZ® XR (tofacitinib) extended release 11 mg once…
Read More...